Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 355 (9216), 1665-1669
- https://doi.org/10.1016/s0140-6736(00)02236-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Dyspepsia in the Community Is Linked to Smoking and Aspirin Use but Not to Helicobacter pylori InfectionArchives of Internal Medicine, 1998
- Can eradicating H pylori prevent gastric cancer?The Lancet, 1998
- Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: the case for.British Medical Bulletin, 1998
- What Role Does Helicobacter pylori Play in Dyspepsia and Nonulcer Dyspepsia? Arguments For and Against H. pylori Being Associated With Dyspeptic SymptomsGastroenterology, 1997
- Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromesGut, 1997
- Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitisGastroenterology, 1997
- Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trialsThe Lancet, 1996
- Helicobacter pyloriand Gastric CancerScandinavian Journal of Gastroenterology, 1996
- Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community.Gut, 1994
- Duodenal ulcer: the villain unmasked?BMJ, 1991